Medical News

RSS

Agence France-Presse reports on efforts to eradicate sleeping sickness in sub-Saharan Africa

Agence France-Presse reports on Human African trypanosomiasis, "commonly known as sleeping sickness, which is transmitted by tsetse flies found in 36 sub-Saharan African countries," writing, "Without treatment in four months to a year, 'the parasite penetrates into the brain, causing serious neurological symptoms, until death,' said Doctor Benedict Blaynay, head of neglected tropical diseases at French pharmaceutical giant Sanofi."

12 Jun 2012

Premature cancer death risk may be increased by dental plaque

Persistent dental plaque may increase the risk of dying early from cancer, suggests an observational study published in the online journal BMJ Open.

12 Jun 2012

Study shows how infections provoke tissues into becoming cancerous

One of the biggest risk factors for liver, colon or stomach cancer is chronic inflammation of those organs, often caused by viral or bacterial infections. A new study from MIT offers the most comprehensive look yet at how such infections provoke tissues into becoming cancerous.

12 Jun 2012

Positive airway pressure reduces depressive symptoms in patients with OSA

Patients seen at the Cleveland Clinic Sleep Disorders Center who used positive airway pressure (PAP) to treat their obstructive sleep apnea (OSA) had improvements in their depressive symptoms, even if they followed the prescribed PAP regimen only partly, a new study reports.

12 Jun 2012

Almased helps patients with type 2 diabetes lose weight, gain better sugar control

A pilot study shows that a protein-rich meal replacement made from soy, yogurt, and honey (Almased) helps patients with type 2 diabetes lose weight, gain better control of their blood sugar, and decrease their daily insulin dose. Patients in the study also lowered their body mass index (BMI), waist and hip circumference, and fasting glucose levels, while improving their HDL-cholesterol and triglycerides.

12 Jun 2012

SafeStitch Medical to present AMID Hernia Fixation Device at AWR conference

SafeStitch Medical, Inc., will attend the Abdominal Wall Reconstruction Conference (AWR) in Washington DC, June 14-16, 2012 to present the AMID Hernia Fixation Device.

12 Jun 2012

UNAIDS governing body calls for range of recommendations to strengthen global HIV response

"The Programme Coordinating Board -- governing body of the Joint United Nations Programme on HIV/AIDS (UNAIDS) -- concluded its 30th session on 7 June calling for a range of recommendations to strengthen the global HIV response," a UNAIDS press release reports.

12 Jun 2012

AMS announces FDA clearance of MEVION S250 Proton Therapy System

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement from Mevion Medical Systems, Inc. regarding Mevion Medical Systems' receipt of FDA 510(k) clearance for its MEVION S250 Proton Therapy System.

12 Jun 2012

New set of computer models predicts negative side effects in current drugs

A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according to a paper appearing online this week in the journal Nature.

12 Jun 2012

African-American survivors of prostate cancer have unmet psychosocial needs

Researchers at Moffitt Cancer Center have found that in African-American families where men are diagnosed with prostate cancer, they have unmet psychosocial needs that affect their survivorship, as well as family and social relationships.

12 Jun 2012

CRT, BioInvent partner to identify new therapeutic antibodies in oncology

BioInvent International AB and Cancer Research Technology Ltd (CRT), the commercial arm of Cancer Research UK, announced today that they have entered a collaboration with Queen Mary, University of London, to identify new therapeutic antibodies in oncology.

12 Jun 2012

India to host parallel conference for those who can't attend International AIDS Conference in U.S.

"When stakeholders from across the world converge at Washington next month to participate in the International AIDS Conference (IAC) to share their experience and evaluations and to influence both popular and official perceptions and practices for curbing HIV/AIDS, India will host a parallel event for those who cannot make it there," the Hindu reports.

12 Jun 2012

Routine screening with echocardiogram can detect more cases of RHD

Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.

12 Jun 2012

Syapse introduces Discovery app to organize R&D data and processes

Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of data generated by advanced omics technologies such as next-generation sequencing.

12 Jun 2012

Aminoacyl-tRNA synthetases important targets for development of new drugs against major diseases

Researchers at the University of Gothenburg, Sweden, are working to develop substances that can prevent parasites, bacteria and fungi from producing essential proteins, research that could, in the long term, lead to new drugs for several major diseases.

12 Jun 2012

Pharmanest commences SHACT Phase II study in women

Today, Pharmanest AB announced that the first patient has been dosed in a randomized Phase II study of SHACT, a product developed for pain relief associated with intrauterine device (IUD) insertion. Karolinska Development AB (STO:KDEV) owns 58.9 percent of Pharmanest.

12 Jun 2012

Sept. 11 compensation fund to cover cancer costs

A Sept. 11 compensation fund will cover the treatment of many different kinds of cancers -- at a cost of up to $147 million -- for people exposed to toxic material during and after the attacks.

12 Jun 2012

Researchers demonstrate effectiveness of a potential new therapy for stroke patients

Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke.

12 Jun 2012

Hepatitis C more prevalent among homeless adults in downtown Los Angeles

Recent government studies show that hepatitis C, which can destroy the liver and necessitate a liver transplant, now kills more American adults than AIDS, and new UCLA research shows just how prevalent the disease is among homeless adults in downtown Los Angeles.

12 Jun 2012

Initial trial results from KYTHERA’s second of two Phase III trials with ATX-101

KYTHERA Biopharmaceuticals, Inc. today announced the presentation of initial trial results from Study ATX-101-10-17, the second of two pivotal European Phase III clinical trials with ATX-101, a facial injectable drug for the aesthetic treatment of submental fat, which commonly presents as an undesirable double chin.

12 Jun 2012

Medical News

Agence France-Presse reports on efforts to eradicate sleeping sickness in sub-Saharan Africa

Premature cancer death risk may be increased by dental plaque

Study shows how infections provoke tissues into becoming cancerous

Positive airway pressure reduces depressive symptoms in patients with OSA

Almased helps patients with type 2 diabetes lose weight, gain better sugar control

SafeStitch Medical to present AMID Hernia Fixation Device at AWR conference

UNAIDS governing body calls for range of recommendations to strengthen global HIV response

AMS announces FDA clearance of MEVION S250 Proton Therapy System

New set of computer models predicts negative side effects in current drugs

African-American survivors of prostate cancer have unmet psychosocial needs

CRT, BioInvent partner to identify new therapeutic antibodies in oncology

India to host parallel conference for those who can't attend International AIDS Conference in U.S.

Routine screening with echocardiogram can detect more cases of RHD

Syapse introduces Discovery app to organize R&D data and processes

Aminoacyl-tRNA synthetases important targets for development of new drugs against major diseases

Pharmanest commences SHACT Phase II study in women

Sept. 11 compensation fund to cover cancer costs

Researchers demonstrate effectiveness of a potential new therapy for stroke patients

Hepatitis C more prevalent among homeless adults in downtown Los Angeles

Initial trial results from KYTHERA’s second of two Phase III trials with ATX-101

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News